Posterior subcapsular cataract in nephrotic children receiving steroid therapy.
D000293:Adolescent; D002386:Cataract / Q000139:chemically induced* / Q000175:diagnosis; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D010248:Paramethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D012189:Retrospective Studies; D013997:Time Factors; D014792:Visual Acuity / Q000187:drug effects
D003907:Dexamethasone; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D010248:Paramethasone